Search
All
Animab, a venture spin-off from VIB, announces today that it has successfully concluded a 3.4 M€ seed financing round. The company develops monoclonal antibodies for oral...
In the video lectures, Amy Sussman explains which patients are most at risk for renal disease, ways to prevent it, and how to diagnose it early.
Following the announcement on July 31, 2020 of the entry into exclusive negotiations between ATEME and the main shareholders of Anevia and the completion, by these latest, of...
This category recognises the most impactful & innovative financial products and services operating globally across numerous areas, including Retail & Payments, Banking, Fraud &...
Federation Bio, a microbial therapeutics company targeting diseases in which the human microbiome can play a curative role, today announced that it has closed a $50 million...
LARQ was started with a simple vision where innovative technology can be combined with inspirational design to help people access pristine drinking water easily and...
Galecto., a privately-held biotechnology company focused on the development of novel treatments for fibrosis and cancer, announced today the successful completion of a $64...
ENTEROME SA, a clinical-stage biopharmaceutical company leveraging its unique knowledge of the microbiome-immunoinflammation axis to develop next-generation therapeutics, today...
Siolta’s live biotherapeutic product (LBP) platform is designed to develop microbiome-based medicines and diagnostics for the prevention and treatment of chronic diseases in...
